ConductScience.org, home

Trial · NCT06643871

Registered outcomes34

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCompletion rate of the DYNAMO-PSY programFrom enrollment to the end of the program at 15 weeks
The main objective will be to assess the completion rate of the dynamopsy program. Then, the primary outcome measure will be the completion of the program by the participant (Yes/No). For each patient included in the study, the number of sessions completed will be recorded. The DYNAMO-PSY program consists of 20 sessions in total. The DYNAMO-PSY program is considered completed when the patient has completed 20 sessions (otherwise, the program is considered abandoned). The completion rate to the DYNAMO-PSY program will be calculated as the proportion : number of patients who completed the program / number of patients included in the study.
SecondarySocial and Occupational Functioningat enrollment and at 15 weeksTotal score at SOFAS (Social and Occupational Functioning Assessment Scale)
SecondaryGlobal Functionningat enrollment and at 15 weeksTotal score at Global Assessment of Functioning (GAF) scale
SecondaryExecutive functions - Inhibitionat the enrollment and at 15 weeksScore at Stroop Test
SecondaryExecutive functions : Cognitive flexibilityat the enrollment and at 15 weeksScore at Trail Making Test
SecondaryExecutive functions - symptoms inventoryat the enrollment and at 15 weeksComposite executive globale Score (CEG) at the BRIEF questionnaire ( Behavior Rating Inventory of Executive Function ). Questionnaire fulfilled by the patient himself.
SecondaryMemory : Digit Spanat enrollment and at 15 weeksTotal score at Digit Span task
SecondaryMemory : visuospatial working memoryat enrollment and at 15 weeksTotal score at Corsi block - taping task
SecondaryMemory : Episodic memoryat enrollment and at 15 weeksTotal Score at MEM III task
SecondaryMemory : Processing speed (visual perception)at enrollment and at 15 weeksTotal score at Symbol Search task
SecondaryAttentionat enrollment and at 15 weeksTotal score at D2R task
SecondaryAdherence to antipsychotic treatmentat enrollment and at 15 weeksTotal score at MARS (Medication Adherence Rating Scale) autoquestionnaire
SecondaryWeightat enrollment and at 15 weeksWeight (in kg, assessed with a bioimpedance scale)
SecondaryBody mass indexat enrollment and at 15 weeksCalculated as : weight / height\^2
Secondarywaist circumferenceat enrollment and at 15 weeksin cm, measured with a tape measure
Secondaryfasting blood glucose concentrationat enrollment and at 15 weeksfasting blood glucose concentration (in mmol/l)
Secondaryblood triglyceride levelsat enrollment and at 15 weeksblood triglyceride levels (mmol/l)
SecondaryTotal cholesterol levelat enrollment and at 15 weeksTotal cholesterol blood level in mmol/L
SecondaryHDL cholesterol levelat enrollment and at 15 weeksHDL cholesterol blood level in mmol/L
SecondaryLDL cholesterol levelat enrollment and at 15 weeksLDL cholesterol blood level in mmol/L

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06643871/registered